Anti-Saccharomyces cerevisiae (ASCA) in patients with severe obesity undergoing bariatric surgery: 12-month follow-up.

Anti-Saccharomyces cerevisiae (ASCA) in patients with severe obesity undergoing bariatric surgery: 12-month follow-up.

Severe obesity is linked to a low-grade inflammatory process due to enlarged adipose tissue, resulting in elevated pro-inflammatory cytokines. Bariatric surgery induces anatomical changes, causing intestinal inflammation marked by anti-Saccharomyces cerevisiae (ASCA) antibodies. This study aimed to...

Full description

Bibliographic Details
Main Authors: Emerita Quintina de Andrade Moura, Bruno Fonseca Nunes, Letícia de Oliveira Souza Bratti, Fabíola Branco Filippin Monteiro
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:Clinical Immunology Communications
Subjects:
Obesity
Bariatric surgery
ASCA
Saccharomyces cerevisiae
Inflammation
Online Access:http://www.sciencedirect.com/science/article/pii/S2772613424000027

Internet

http://www.sciencedirect.com/science/article/pii/S2772613424000027

Similar Items